BNP Paribas Financial Markets
NPCE icon

BNP Paribas Financial Markets’s Neuropace NPCE Stock Holding History

BNP Paribas Financial Markets’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
87,677
+11,706
+15% +$188K ﹤0.01% 3091
2026
Q1 		$999K Buy
75,971
+29,054
+62% +$436K ﹤0.01% 3134
2025
Q4 		$724K Buy
46,917
+28,161
+150% +$377K ﹤0.01% 3337
2025
Q3 		$193K Buy
18,756
+11,972
+176% +$113K ﹤0.01% 4025
2025
Q2 		$75.6K Sell
6,784
-17,734
-72% -$222K ﹤0.01% 4106
2025
Q1 		$301K Buy
24,518
+21,952
+855% +$275K ﹤0.01% 3479
2024
Q4 		$28.7K Buy
+2,566
New +$22.3K ﹤0.01% 4623

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Financial Markets's NPCE Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Neuropace (NPCE) stake by 15% in Q2 2026, buying an estimated $188K and bringing the position to 87,677 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3091.

BNP Paribas Financial Markets first reported a position in NPCE in Q4 2024 and has held it in 7 quarters since. 104 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • BNP Paribas Financial Markets held 87,677 shares of Neuropace worth $1.39M as of Q2 2026.
  • BNP Paribas Financial Markets bought 11,706 Neuropace shares in Q2 2026, an estimated $188K.
  • Neuropace made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3091 holding.
  • BNP Paribas Financial Markets first reported a position in Neuropace in Q4 2024 and has held it in 7 quarters since.
  • 104 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.